Mail

UK markets close in 2 hours 18 minutes

FTSE 100
8,209.84
-37.95(-0.46%)
FTSE 250
20,274.87
-88.56(-0.43%)
AIM
765.31
-2.72(-0.35%)
GBP/EUR
1.1840
+0.0003(+0.03%)
GBP/USD
1.2645
-0.0042(-0.33%)
Bitcoin GBP
48,543.98
+209.18(+0.43%)

The cost of following England at Euro 2024

What could your money earn if you invested your football spending elsewhere

Sea Mild Biotechnology Co., Ltd. (7516.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD

Add to watchlist

9.55

+0.06

(+0.63%)

At close: 02:29PM CST

Currency in TWD

Valuation measures⁴

Market cap (intra-day)	182.47M
Enterprise value	181.05M
Trailing P/E	29.53
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	0.71
Price/book (mrq)	2.59
Enterprise value/revenue	0.70
Enterprise value/EBITDA	8.39

Trading information

Stock price history

Beta (5Y monthly)	-0.87
52-week change ³	-22.86%
S&P500 52-week change ³	24.96%
52-week high ³	13.20
52-week low ³	8.85
50-day moving average ³	9.67
200-day moving average ³	10.35

Share statistics

Avg vol (3-month) ³	43.59k
Avg vol (10-day) ³	50.61k
Shares outstanding ⁵	19.31M
Implied shares outstanding ⁶	19.41M
Float ⁸	N/A
% held by insiders ¹	N/A
% held by institutions ¹	N/A
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	769.28:1000
Last split date ³	21 Jan 2021

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	2.41%
Operating margin (ttm)	2.40%

Management effectiveness

Return on assets (ttm)	1.74%
Return on equity (ttm)	9.17%

Income statement

Revenue (ttm)	257.02M
Revenue per share (ttm)	13.31
Quarterly revenue growth (yoy)	12.20%
Gross profit (ttm)	N/A
EBITDA	7.38M
Net income avi to common (ttm)	6.19M
Diluted EPS (ttm)	0.32
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	46.63M
Total cash per share (mrq)	2.41
Total debt (mrq)	44.25M
Total debt/equity (mrq)	62.85%
Current ratio (mrq)	1.33
Book value per share (mrq)	3.65

Cash flow statement

Operating cash flow (ttm)	8.84M
Levered free cash flow (ttm)	2.12M